SAN FRANCISCO, March 27, 2025 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today reported ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Harmonic Bio, a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback